Cardinal Health (NYSE:CAH) Issues FY25 Earnings Guidance

Cardinal Health (NYSE:CAH) updated its FY25 earnings guidance on Thursday. The company provided EPS guidance of at least $7.50 for the period, compared to the consensus EPS estimate of $7.89. Cardinal Health also updated its FY24 guidance to $7.30-7.40 EPS.

Analyst Ratings Changes

Several brokerages have commented on CAH. Leerink Partnrs reaffirmed an outperform rating on shares of Cardinal Health in a research note on Monday, February 26th. SVB Leerink assumed coverage on shares of Cardinal Health in a report on Monday, February 26th. They issued an outperform rating and a $125.00 price target for the company. StockNews.com upgraded shares of Cardinal Health from a buy rating to a strong-buy rating in a report on Thursday. Wells Fargo & Company reduced their target price on shares of Cardinal Health from $96.00 to $94.00 and set an underweight rating for the company in a report on Monday, April 29th. Finally, Argus upgraded shares of Cardinal Health from a hold rating to a buy rating in a report on Friday, February 9th. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating, seven have given a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, the company has an average rating of Moderate Buy and a consensus target price of $105.79.

Cardinal Health Stock Performance

NYSE:CAH traded down $4.07 during mid-day trading on Friday, reaching $98.91. 3,446,183 shares of the company’s stock were exchanged, compared to its average volume of 2,028,678. Cardinal Health has a one year low of $77.56 and a one year high of $116.04. The firm has a market capitalization of $24.06 billion, a PE ratio of 43.96, a price-to-earnings-growth ratio of 0.99 and a beta of 0.71. The business’s fifty day simple moving average is $109.10 and its two-hundred day simple moving average is $105.09.

Cardinal Health (NYSE:CAH) last released its quarterly earnings results on Thursday, May 2nd. The company reported $2.08 EPS for the quarter, topping analysts’ consensus estimates of $1.95 by $0.13. Cardinal Health had a net margin of 0.25% and a negative return on equity of 54.74%. The business had revenue of $54.90 billion for the quarter, compared to analyst estimates of $56.05 billion. During the same period last year, the firm earned $1.74 earnings per share. Cardinal Health’s revenue for the quarter was up 8.7% compared to the same quarter last year. As a group, equities research analysts forecast that Cardinal Health will post 7.34 EPS for the current year.

Cardinal Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Monday, April 15th. Shareholders of record on Monday, April 1st were paid a dividend of $0.5006 per share. The ex-dividend date of this dividend was Thursday, March 28th. This represents a $2.00 dividend on an annualized basis and a yield of 2.02%. Cardinal Health’s payout ratio is 88.89%.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.